금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Two More Oil Tankers Attacked Near Strait of Hormuz
Two more tankers were attacked near the Strait of Hormuz on Sunday, one in Hormuz and the other off ...
Asian shares are mixed and oil prices fall about $1.50 as Trump says US will buy diesel from Russia
BANGKOK (AP) — Asian shares were mixed and oil prices fell about $1. President Donald Trump’s plan t...
‘Worrying omens’ lurk over global economy despite resilient growth
Research for the FT shows major economies are withstanding the Iran shock but concerns about rising ...
Asian tech rally drives mild gains as U.S.-China summit pressures Beijing shares
STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses
Micware prices upsized IPO of 2.85M ADS at $8 each
Northland Power beats top-line estimates; reaffirms FY26 outlook
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory dest ...
Galiano Gold reports mixed Q1 results; updates FY26 outlook
Copa Holdings GAAP EPS of $5.16 beats by $1.20, revenue of $1.05B beats by $20M
Trump-Xi Summit Puts Nvidia, Boeing And 500-Jet Deal In Focus
Investors are watching chips, aerospace, agriculture and rare earths as Trump and Xi head into high-stakes talks.
Worksport reaffirms $35M-$42M fiscal 2026 revenue guidance while shifting to annual guidance updates
Omeros expects YARTEMLEA to drive company-wide positive cash flow within 18 months as early TA-TMA uptake builds
Asia markets mixed as Trump-Xi summit, AI trade dominate
Asian markets were mixed Thursday as investors weighed a high-stakes US-China summit and persistent inflation concerns, which tempered optimism fuelled by record highs on Wall Street.The cautious mood ...
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
While Edwards Lifesciences has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.